An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure

CompletedOBSERVATIONAL
Enrollment

352

Participants

Timeline

Start Date

May 21, 2022

Primary Completion Date

August 28, 2024

Study Completion Date

August 28, 2024

Conditions
Hyperkalemia
Trial Locations (32)

486-8510

Research Site, Kasugai

457-8511

Research Site, Nagaoka

460-0001

Research Site, Nagaoka

271-0077

Research Site, Matsudo

818-0058

Research Site, Chikushino-shi

820-8505

Research Site, Iizuka-shi

802-8555

Research Site, Kitakyushu-shi

370-0001

Research Site, Takasaki

370-8537

Research Site, Takasaki

729-0104

Research Site, Fukuyama

730-8518

Research Site, Hirosima-shi,Naka-ku

924-8588

Research Site, Hakusan

920-8650

Research Site, Kanazawa

210-0852

Research Site, Kawasaki-shi,Kawasaki-ku

216-8511

Research Site, Kawasaki-shi,Miyamae-ku

511-0061

Research Site, Kuwana

982-8502

Research Site, Sendai

399-8292

Research Site, Azumino

386-8610

Research Site, Ueda

940-8653

Research Site, Nagaoka

530-0012

Research Site, Osaka-shi,Kita-ku

593-8304

Research Site, Sakai

113-8431

Research Site, Bunkyo

113-8519

Research Site, Bunkyo

173-0032

Research Site, tabashi City

173-8610

Research Site, tabashi City

890-0075

Research Site, Kagoshima

781-0082

Research Site, Kochi

410-2295

Research Site, Shizuoka

321-0293

Research Site, Tochigi

939-8511

Research Site, Toyama

990-8533

Research Site, Yamagata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT05297409 - An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure | Biotech Hunter | Biotech Hunter